Mutations in GRIN2A are strongly associated with childhood epilepsy/aphasia syndromes [50–53] and there is evidence for dysregulation of NMDA receptor subunit composition in Rett Syndrome [30, 54] and in Parkinson’s disease [55, 56]. This evidence concerns the gene GRIN2A and atypical Rett syndrome.